Aligned Genetics, Inc. (KOSDAQ:238120)
2,945.00
+25.00 (0.86%)
At close: Nov 20, 2026
| Market Cap | 41.40B -10.5% |
| Revenue (ttm) | 16.16B -5.9% |
| Net Income | 4.64B +39.9% |
| EPS | 329.61 +41.9% |
| Shares Out | 14.06M |
| PE Ratio | 8.93 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,208 |
| Open | 2,845.00 |
| Previous Close | 2,920.00 |
| Day's Range | 2,845.00 - 2,945.00 |
| 52-Week Range | 2,345.00 - 6,050.00 |
| Beta | 0.51 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Mar 9, 2027 |